A detailed history of Bartlett & Co. LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Bartlett & Co. LLC holds 26,169 shares of LLY stock, worth $20.8 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
26,169
Previous 25,664 1.97%
Holding current value
$20.8 Million
Previous $13.8 Million 10.26%
% of portfolio
0.25%
Previous 0.25%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 08, 2024

BUY
$525.19 - $619.13 $265,220 - $312,660
505 Added 1.97%
26,169 $15.2 Million
Q3 2023

Oct 10, 2023

BUY
$434.7 - $599.3 $28,690 - $39,553
66 Added 0.26%
25,664 $13.8 Million
Q2 2023

Jul 14, 2023

BUY
$350.74 - $468.98 $1.14 Million - $1.53 Million
3,255 Added 14.57%
25,598 $12 Million
Q1 2023

Apr 06, 2023

BUY
$310.63 - $364.82 $165,876 - $194,813
534 Added 2.45%
22,343 $7.67 Million
Q4 2022

Jan 04, 2023

SELL
$321.55 - $374.67 $49,840 - $58,073
-155 Reduced 0.71%
21,809 $7.98 Million
Q3 2022

Oct 17, 2022

SELL
$296.48 - $337.87 $58,110 - $66,222
-196 Reduced 0.88%
21,964 $7.1 Million
Q2 2022

Aug 02, 2022

SELL
$278.73 - $327.27 $46,826 - $54,981
-168 Reduced 0.75%
22,160 $7.19 Million
Q1 2022

May 13, 2022

BUY
$234.69 - $291.66 $29,570 - $36,749
126 Added 0.57%
22,328 $6.39 Million
Q4 2021

Mar 08, 2022

BUY
$224.85 - $279.04 $317,263 - $393,725
1,411 Added 6.79%
22,202 $6.13 Million
Q3 2021

Oct 15, 2021

BUY
$221.6 - $272.71 $111,908 - $137,718
505 Added 2.49%
20,791 $4.8 Million
Q2 2021

Jul 19, 2021

SELL
$180.55 - $233.54 $18,055 - $23,354
-100 Reduced 0.49%
20,286 $4.66 Million
Q1 2021

Apr 19, 2021

SELL
$164.32 - $212.72 $47,652 - $61,688
-290 Reduced 1.4%
20,386 $3.81 Million
Q4 2020

Jan 20, 2021

SELL
$130.46 - $172.63 $4,044 - $5,351
-31 Reduced 0.15%
20,676 $3.49 Million
Q3 2020

Oct 20, 2020

BUY
$146.22 - $169.13 $2,193 - $2,536
15 Added 0.07%
20,707 $3.07 Million
Q2 2020

Aug 03, 2020

BUY
$136.42 - $164.18 $160,293 - $192,911
1,175 Added 6.02%
20,692 $3.4 Million
Q1 2020

May 07, 2020

SELL
$119.05 - $147.35 $59,048 - $73,085
-496 Reduced 2.48%
19,517 $2.71 Million
Q3 2019

Nov 04, 2019

BUY
$106.79 - $116.16 $1.18 Million - $1.28 Million
11,010 Added 122.29%
20,013 $2.24 Million
Q2 2019

Jul 24, 2019

BUY
$110.79 - $129.32 $1,218 - $1,422
11 Added 0.12%
9,003 $997,000
Q1 2019

Apr 23, 2019

BUY
$111.31 - $131.02 $5,565 - $6,551
50 Added 0.56%
8,992 $0
Q4 2018

Jan 23, 2019

SELL
$105.9 - $118.64 $28,063 - $31,439
-265 Reduced 2.88%
8,942 $1.04 Million
Q3 2018

Oct 15, 2018

SELL
$85.86 - $107.31 $13,737 - $17,169
-160 Reduced 1.71%
9,207 $988,000
Q1 2018

Apr 25, 2018

SELL
$74.21 - $87.6 $22,559 - $26,630
-304 Reduced 3.14%
9,367 $725,000
Q3 2017

Oct 23, 2017

BUY
$77.07 - $85.54 $745,343 - $827,257
9,671
9,671 $827,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Bartlett & Co. LLC Portfolio

Follow Bartlett & Co. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bartlett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bartlett & Co. LLC with notifications on news.